Bullish Case: UL sits at $65.16 with Helium's density peaked at $65 (0.102) and market density at $65 (0.102), both curves centered on the current price. The Helium term structure shows event vol collapsing from 116% (10/24) to ~19-20% long-dated, meaning a benign next 7-10 days releases premium. FTC early termination cleared McCormick-UL food deal; CMA Phase 1 deadline Nov 11 is a real unlock, and Polymarket odds for merger by mid-2027 ticked up 47%. Defensive staples with ~3.4% yield plus AI-driven capacity gains support a drift toward $67-68.

Bearish Case: Put volume exceeds calls by 48% despite only 8% net bullish risk — hedging demand dominates. Term structure is sharply backwardated (10/24 at 116% Helium vs 19% out-months) pricing imminent event/tail risk. The $63-64 zone carries heavy market density (0.048-0.062), and deep-OTM put IVs (121-227%) reveal fat left tails. US CPI beat and Iran-war inflation risk, 6.0x book, -6.5% YoY, and a CMA Phase 2 referral on Nov 11 could snap the McCormick deal and compress the multiple toward $60-62.

Potential Outcomes:

1. Benign event passthrough, 30%: UL stays $64-67; front IV (10/31: 36.9% market) collapses toward ~22% within two weeks — falsifiable via term structure flattening.
2. CMA Phase 1 clears Nov 11, 25%: merger re-rate, UL $66-69; Polymarket Dec-2026 odds jump from 17%.
3. CMA Phase 2 referral, 20%: deal-timeline pressure, UL $62-64; Dec $60P IV (25.4%) rises.
4. Macro/inflation shock, 15%: SPY skew (downside IV 45%+) widens, CPI repeats; UL $58-61.
5. Q3 miss/India weakness, 8%: $57-60 with put OI spike.
6. Regulatory/brand shock, 2%: <$55.

October 20, 2026